Effect of premedication with subcutaneous adrenaline on the pharmacokinetics and immunogenicity of equine whole IgG antivenom in a rabbit model.

[1]  David J. Williams,et al.  Development of a chicken-derived antivenom against the taipan snake (Oxyuranus scutellatus) venom and comparison with an equine antivenom. , 2016, Toxicon : official journal of the International Society on Toxinology.

[2]  David J. Williams,et al.  Neutralization of the neuromuscular inhibition of venom and taipoxin from the taipan (Oxyuranus scutellatus) by F(ab')2 and whole IgG antivenoms. , 2016, Toxicology letters.

[3]  G. Solano,et al.  Assessing endotoxins in equine-derived snake antivenoms: Comparison of the USP pyrogen test and the Limulus Amoebocyte Lysate assay (LAL). , 2015, Toxicon : official journal of the International Society on Toxinology.

[4]  David J. Williams,et al.  Antivenomic characterization of two antivenoms against the venom of the taipan, Oxyuranus scutellatus, from Papua New Guinea and Australia. , 2014, The American journal of tropical medicine and hygiene.

[5]  J. Gutiérrez,et al.  Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms. , 2013, Toxicon : official journal of the International Society on Toxinology.

[6]  J. Gutiérrez,et al.  Role of the animal model on the pharmacokinetics of equine-derived antivenoms. , 2013, Toxicon : official journal of the International Society on Toxinology.

[7]  A. Habib.  Effect of Pre-Medication on Early Adverse Reactions Following Antivenom Use in Snakebite , 2011, Drug safety.

[8]  J. Gutiérrez,et al.  Immune response towards snake venoms. , 2011, Inflammation & allergy drug targets.

[9]  J. Gutiérrez,et al.  Antivenoms for snakebite envenomings. , 2011, Inflammation & allergy drug targets.

[10]  J. Aronson,et al.  Low-Dose Adrenaline, Promethazine, and Hydrocortisone in the Prevention of Acute Adverse Reactions to Antivenom following Snakebite: A Randomised, Double-Blind, Placebo-Controlled Trial , 2011, PLoS medicine.

[11]  David J. Williams,et al.  Preclinical Evaluation of Caprylic Acid-Fractionated IgG Antivenom for the Treatment of Taipan (Oxyuranus scutellatus) Envenoming in Papua New Guinea , 2011, PLoS neglected tropical diseases.

[12]  Douglas G Altman,et al.  Animal Research: Reporting in vivo Experiments—The ARRIVE Guidelines , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  E. Wodey,et al.  Effect of epinephrine on epidural, intrathecal, and plasma pharmacokinetics of ropivacaine and bupivacaine in sheep. , 2007, British journal of anaesthesia.

[14]  David J. Williams,et al.  Antivenom use, premedication and early adverse reactions in the management of snake bites in rural Papua New Guinea. , 2007, Toxicon : official journal of the International Society on Toxinology.

[15]  J. Plummer,et al.  The Effect of the Addition of Epinephrine on Early Systemic Absorption of Epidural Ropivacaine in Humans , 2002, Anesthesia and analgesia.

[16]  H. J. de Silva,et al.  Low dose subcutaneous adrenaline to prevent acute adverse reactions to antivenom serum in people bitten by snakes: randomised,placebo controlled trial , 1999, BMJ.

[17]  笠井 憲雪.  International Guiding Principles for Biomedical Research Involving Animals , 1985, Alternatives to laboratory animals : ATLA.